News Focus
News Focus
icon url

lasers

07/17/12 3:36 PM

#21648 RE: Steges #21641

As I envision 'Third Party Funding" Elite licenses and makes ELI-216 Morphine for Watson/Actavis in exchange for Watson/Actavis funding the ELI-216 Phase III trials of $6 to $7 mil.